Vice President Therapeutic Antibody Discovery @ Biosion, Inc. (May 2019 - July 2023)
Director of Research and Development @ FZata, Inc (August 2016 - May 2019)
Sr. Scientist @ Dophen BioMed, Inc. (June 2015 - August 2016)
Assistant Professor @ University of Maryland School of Dentistry (March 2009 - May 2015)
Senior Scientist, Oncology @ (January 2001 - January 2009)
Postdoc to Instructor @ (August 1995 - December 2000)
Mark Education
University of Milan, Italy
Doctor of Philosophy (Ph.D.) (Biotechnology)
1990-2005
中国药科大学
Master's degree (Neuropharmacology)
1984-1987
Mark Skills
Molecular Biology
Biotechnology
Oncology
Cell
Genetics
Immunohistochemistry
Microsoft Excel
Life Sciences
Cell Culture
Attorney
In Vitro
Customer Service
In Vivo
Pharmacology
Drug Discovery
Mark Summary
Mark, based in Ellicott City, MD, US, is currently a Chief Scientific Officer at Yangtze River Pharmaceutical Group Pharmaceutical Co., Ltd.. Mark brings experience from previous roles at Biosion, Inc., FZata, Inc, Dophen BioMed, Inc. and University of Maryland School of Dentistry. Mark holds a 1990 - 2005 Doctor of Philosophy (Ph.D.) in Biotechnology @ University of Milan, Italy. With a robust skill set that includes Molecular Biology, Biotechnology, Oncology, Cell, Genetics and more. Mark has 2 emails and 5 mobile phone numbers on RocketReach.
Looking for a different Mark?
Find contact details for 700 million professionals.